FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161392015> ?p ?o ?g. }

• W2161392015 endingPage "1562" @default.
• W2161392015 startingPage "1551" @default.
• W2161392015 abstract "Previous studies have suggested that blockade of the renin-angiotensin system may prevent diabetes in people with cardiovascular disease or hypertension.In a double-blind, randomized clinical trial with a 2-by-2 factorial design, we randomly assigned 5269 participants without cardiovascular disease but with impaired fasting glucose levels (after an 8-hour fast) or impaired glucose tolerance to receive ramipril (up to 15 mg per day) or placebo (and rosiglitazone or placebo) and followed them for a median of 3 years. We studied the effects of ramipril on the development of diabetes or death, whichever came first (the primary outcome), and on secondary outcomes, including regression to normoglycemia.The incidence of the primary outcome did not differ significantly between the ramipril group (18.1%) and the placebo group (19.5%; hazard ratio for the ramipril group, 0.91; 95% confidence interval [CI], 0.81 to 1.03; P=0.15). Participants receiving ramipril were more likely to have regression to normoglycemia than those receiving placebo (hazard ratio, 1.16; 95% CI, 1.07 to 1.27; P=0.001). At the end of the study, the median fasting plasma glucose level was not significantly lower in the ramipril group (102.7 mg per deciliter [5.70 mmol per liter]) than in the placebo group (103.4 mg per deciliter [5.74 mmol per liter], P=0.07), though plasma glucose levels 2 hours after an oral glucose load were significantly lower in the ramipril group (135.1 mg per deciliter [7.50 mmol per liter] vs. 140.5 mg per deciliter [7.80 mmol per liter], P=0.01).Among persons with impaired fasting glucose levels or impaired glucose tolerance, the use of ramipril for 3 years does not significantly reduce the incidence of diabetes or death but does significantly increase regression to normoglycemia. (ClinicalTrials.gov number, NCT00095654 [ClinicalTrials.gov].)." @default.
• W2161392015 created "2016-06-24" @default.
• W2161392015 creator A5005906845 @default.
• W2161392015 creator A5013408607 @default.
• W2161392015 creator A5018419311 @default.
• W2161392015 creator A5024577116 @default.
• W2161392015 creator A5039145780 @default.
• W2161392015 creator A5040356261 @default.
• W2161392015 creator A5047726859 @default.
• W2161392015 creator A5049740900 @default.
• W2161392015 creator A5051052331 @default.
• W2161392015 creator A5058515475 @default.
• W2161392015 creator A5078471246 @default.
• W2161392015 creator A5080292021 @default.
• W2161392015 date "2006-10-12" @default.
• W2161392015 modified "2023-10-13" @default.
• W2161392015 title "Effect of Ramipril on the Incidence of Diabetes" @default.
• W2161392015 cites W1663109189 @default.
• W2161392015 cites W1974548284 @default.
• W2161392015 cites W1980567021 @default.
• W2161392015 cites W2003106879 @default.
• W2161392015 cites W2023755744 @default.
• W2161392015 cites W2059165993 @default.
• W2161392015 cites W2074427854 @default.
• W2161392015 cites W2090824142 @default.
• W2161392015 cites W2102979143 @default.
• W2161392015 cites W2106244081 @default.
• W2161392015 cites W2110424396 @default.
• W2161392015 cites W2113995750 @default.
• W2161392015 cites W2115607452 @default.
• W2161392015 cites W2123744385 @default.
• W2161392015 cites W2134235461 @default.
• W2161392015 cites W2146851676 @default.
• W2161392015 cites W2153769155 @default.
• W2161392015 cites W2158822657 @default.
• W2161392015 cites W2172032309 @default.
• W2161392015 cites W2332951586 @default.
• W2161392015 cites W2396772514 @default.
• W2161392015 cites W2562329777 @default.
• W2161392015 cites W4237597297 @default.
• W2161392015 cites W4254784503 @default.
• W2161392015 doi "https://doi.org/10.1056/nejmoa065061" @default.
• W2161392015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16980380" @default.
• W2161392015 hasPublicationYear "2006" @default.
• W2161392015 type Work @default.
• W2161392015 sameAs 2161392015 @default.
• W2161392015 citedByCount "671" @default.
• W2161392015 countsByYear W21613920152012 @default.
• W2161392015 countsByYear W21613920152013 @default.
• W2161392015 countsByYear W21613920152014 @default.
• W2161392015 countsByYear W21613920152015 @default.
• W2161392015 countsByYear W21613920152016 @default.
• W2161392015 countsByYear W21613920152017 @default.
• W2161392015 countsByYear W21613920152018 @default.
• W2161392015 countsByYear W21613920152019 @default.
• W2161392015 countsByYear W21613920152020 @default.
• W2161392015 countsByYear W21613920152021 @default.
• W2161392015 countsByYear W21613920152022 @default.
• W2161392015 countsByYear W21613920152023 @default.
• W2161392015 crossrefType "journal-article" @default.
• W2161392015 hasAuthorship W2161392015A5005906845 @default.
• W2161392015 hasAuthorship W2161392015A5013408607 @default.
• W2161392015 hasAuthorship W2161392015A5018419311 @default.
• W2161392015 hasAuthorship W2161392015A5024577116 @default.
• W2161392015 hasAuthorship W2161392015A5039145780 @default.
• W2161392015 hasAuthorship W2161392015A5040356261 @default.
• W2161392015 hasAuthorship W2161392015A5047726859 @default.
• W2161392015 hasAuthorship W2161392015A5049740900 @default.
• W2161392015 hasAuthorship W2161392015A5051052331 @default.
• W2161392015 hasAuthorship W2161392015A5058515475 @default.
• W2161392015 hasAuthorship W2161392015A5078471246 @default.
• W2161392015 hasAuthorship W2161392015A5080292021 @default.
• W2161392015 hasBestOaLocation W21613920151 @default.
• W2161392015 hasConcept C126322002 @default.
• W2161392015 hasConcept C134018914 @default.
• W2161392015 hasConcept C142724271 @default.
• W2161392015 hasConcept C176674119 @default.
• W2161392015 hasConcept C204787440 @default.
• W2161392015 hasConcept C207103383 @default.
• W2161392015 hasConcept C27016395 @default.
• W2161392015 hasConcept C27081682 @default.
• W2161392015 hasConcept C2779611605 @default.
• W2161392015 hasConcept C2779888176 @default.
• W2161392015 hasConcept C44249647 @default.
• W2161392015 hasConcept C555293320 @default.
• W2161392015 hasConcept C71924100 @default.
• W2161392015 hasConcept C84393581 @default.
• W2161392015 hasConceptScore W2161392015C126322002 @default.
• W2161392015 hasConceptScore W2161392015C134018914 @default.
• W2161392015 hasConceptScore W2161392015C142724271 @default.
• W2161392015 hasConceptScore W2161392015C176674119 @default.
• W2161392015 hasConceptScore W2161392015C204787440 @default.
• W2161392015 hasConceptScore W2161392015C207103383 @default.
• W2161392015 hasConceptScore W2161392015C27016395 @default.
• W2161392015 hasConceptScore W2161392015C27081682 @default.
• W2161392015 hasConceptScore W2161392015C2779611605 @default.
• W2161392015 hasConceptScore W2161392015C2779888176 @default.
• W2161392015 hasConceptScore W2161392015C44249647 @default.

• next